We coordinate cross-border business enquiries involving pharmaceutical products, APIs, healthcare products and related sectors. Each opportunity is assessed by product, origin, destination, counterparties and applicable legal or regulatory requirements.
Trade and distribution enquiries involving Iran may require careful review of product eligibility, local registration, import/export permissions, payment arrangements and the responsibilities of all parties. We help organize the commercial questions and document requests for each eligible opportunity.
Türkiye can be a relevant point for supplier discussions, distribution planning and regional business coordination. The fit of each opportunity depends on the product category, manufacturer, destination market and agreed commercial route.
Requirements differ across Middle Eastern countries and between medicines, APIs, medical devices, nutrition products and other goods. Product registration, labeling, local representation and import permissions should be checked country by country before any market launch or shipment.
Opportunities involving Spain and other European markets can require product-specific assessment, partner qualification, documentation review and careful checks of relevant trade and regulatory rules. This page does not imply a registered office or authorized representation in every European country.
Manufacturer and supplier enquiries involving China or India should be assessed on specification, manufacturing capability, available quality documents, order conditions and destination-market requirements. Supplier qualification and technical acceptance remain the buyer’s responsibility.
NIAZ NET coordinates commercial enquiries for pharmaceutical finished products, active pharmaceutical ingredients, medical devices, brand registration, exclusive agency, technology transfer, contract manufacturing and supply-chain follow-up.
Geographic references describe markets of interest for commercial enquiries; they are not a claim of a local office, guaranteed distribution capability or regulatory authorization in every listed jurisdiction. Availability, legality and transaction feasibility must be confirmed for each product and destination.
